PLIVA is the largest pharmaceutical company in Croatia and one of the leading companies in Southeast Europe. PLIVA is also one of the major exporters in Croatia with over 80% of products intended for exports, and its major markets are USA, Croatia and Russia. Since 2008, PLIVA is a member of the Teva Group, one of the largest global pharmaceutical companies. PLIVA’s production portfolio includes a high number of finished dosage forms covering almost all therapeutic groups and active pharmaceutical ingredients. Focused on development of generic and niche products, PLIVA has the broadest portfolio of generic medicines in Central and Eastern Europe. PLIVA’s success and status may be largely attributed to its in-house research and development of finished dosage forms and active pharmaceutical ingredients. Thanks to the approvals by the US Food and Drug Administration (FDA), the British Medicines and Healthcare Products Regulatory Agency (MHRA) and those of other relevant European agencies, PLIVA is one of the manufacturers complying with the highest global quality standards required for international markets.